MedTrace Logo

Effects of Short-term Intensive Statin Therapy on Lipid Levels

NCT07344610 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2026-01-15

No results posted yet for this study

Summary

Acute cerebral infarction (ACI), often linked to arterial stenosis, is a major cause of death and disability. Statins are cornerstone therapies for secondary prevention, effectively lowering LDL-C and stabilizing plaques. However, patient response to intensive statin therapy varies significantly. This prospective study aims to analyze the short-term lipid-lowering effects and influencing factors of such therapy in ACI patients with stenosis, to guide personalized treatment and improve outcomes.

Conditions

Interventions

DRUG

statin

Atorvastatin 40-80mg/day, Rosuvastatin 20mg/day

Sponsors & Collaborators

  • General Hospital of Shenyang Military Region

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-08
Primary Completion
2026-12-30
Completion
2026-12-30
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07344610 on ClinicalTrials.gov